HYALURONIDASE INJECTION
LIPORASE inj
10 Vials per Box
Professional Hyaluronidase for Filler Correction & Lipolysis Enhancement
π§© Product Overview
Advanced Corrective Enzyme Solution
LIPORASE inj is a specialized depolymerizing enzyme formulation containing 1,500 IU of Hyaluronidase per vial. This professional-grade solution effectively dissolves hyaluronic acid dermal fillers while enhancing the efficacy of fat-dissolving treatments. Each lyophilized powder vial ensures optimal stability and precision in corrective aesthetic procedures.
βοΈ
Active Enzyme
1,500
IU
Hyaluronidase (EP) per vial
π§ͺ
Formulation
Lyophilized
Powder
π¦
Package Size
10
Vials
Complete treatment box
π
Storage
Below 25Β°C
Room Temp
Immediate Results Within 24-48 Hours
π Detailed Specifications
| Specification Category |
Details/Values |
Additional Information |
| Active Ingredient |
Hyaluronidase (EP) 1500 IU |
Depolymerizing enzyme |
| Stabilizing Agent |
Lactose Hydrate 13.3 mg |
Per vial formulation |
| Dissolution Capacity |
3cc HA Filler |
Per vial with 3cc saline |
| Effect Timeline |
Immediate to 24-48 hours |
Complete dissolution period |
| Administration Route |
Subcutaneous/Dermal Injection |
Professional application required |
| Reconstitution |
Sterile Saline Solution |
3-5cc depending on application |
𧬠Ingredients & Composition
Hyaluronidase (EP)A specialized depolymerizing enzyme that specifically targets and breaks down the molecular bonds of hyaluronic acid. This enzyme reduces the viscosity and volume of HA fillers, allowing the body to naturally metabolize and absorb the broken-down components while leaving natural HA intact.Lactose HydrateA pharmaceutical-grade stabilizing agent that maintains the integrity and stability of the lyophilized enzyme powder, ensuring consistent potency and effectiveness throughout the product's shelf life.Lyophilized FormulationAdvanced freeze-drying technology preserves the enzyme's biological activity while providing extended stability and precise dosing control for professional applications.
Active
Hyaluronidase (EP)
1,500 IU
Primary depolymerizing enzyme that specifically targets hyaluronic acid molecular bonds. This highly purified enzyme maintains selective activity against synthetic HA fillers while preserving the body's natural hyaluronic acid, ensuring targeted correction without systemic effects.
Stabilizer
Lactose Hydrate
13.3 mg
Pharmaceutical-grade excipient that maintains enzyme stability in lyophilized form and facilitates smooth reconstitution with saline solution, ensuring consistent enzyme activity and optimal therapeutic outcomes.
π‘ Clinical Benefits & Applications
Filler Correction Applications
Effectively reverses poorly placed, overfilled, or unevenly distributed HA dermal fillers. Resolves nodular formations and granulomas caused by filler complications. Essential for emergency treatment of vascular occlusion cases.
Immediate Dissolution Selective Action Emergency Use
Lipolysis Enhancement
Synergistically enhances fat-dissolving injection effectiveness by improving tissue diffusion and penetration. Aids in cellulite reduction and improves overall treatment outcomes when combined with lipolytic agents.
- Enhanced diffusion of fat-dissolving agents throughout target tissue
- Improved treatment efficacy for stubborn adipose deposits
- Reduction in fibrous cellulite through tissue matrix modification
- Accelerated treatment response and visible results
Professional Versatility
Dual-purpose formulation suitable for both corrective aesthetic procedures and enhancement of body contouring treatments. Compatible with various injection techniques and treatment protocols.
π§ͺ Usage Protocols & Application Guide
1
Preparation & Assessment
Assess the target area and determine the appropriate application protocol. For filler dissolution, evaluate the volume and depth of HA filler. For lipolysis enhancement, prepare the treatment cocktail and determine injection sites.
2
Reconstitution Process
Reconstitute the lyophilized powder with sterile saline: 3cc saline for filler dissolution or 5cc saline for fat-dissolving synergy. Ensure complete dissolution before application.
3
Injection Technique
Administer via subcutaneous or superficial dermal injection using appropriate needle gauge. For filler correction, inject directly into the filler deposit. For lipolysis, distribute evenly throughout the treatment area.
4
Post-Treatment Monitoring
Monitor patient response and effects. Initial results appear immediately with full effects visible within 24-48 hours. Schedule follow-up assessment and additional treatment if required.
π Specific Application Protocols
| Application Type |
Reconstitution Ratio |
Target Area |
Expected Outcome |
| Filler Dissolution |
1 vial + 3cc saline |
HA filler deposits |
Dissolves ~3cc HA filler |
| Lipolysis Enhancement |
1 vial + 5cc saline |
Adipose tissue |
Enhanced fat dissolution |
| Emergency Correction |
1 vial + 3cc saline |
Vascular occlusion area |
Immediate filler breakdown |
| Cellulite Treatment |
1 vial + 5cc saline |
Fibrous cellulite areas |
Improved skin texture |
Important Safety Information
Professional use only. This product requires proper medical training and sterile injection techniques for safe and effective application.
- Contraindicated in patients with known hyaluronidase allergy
- Do not use on infected areas or near recent botulinum toxin injection sites
- Store in sealed container at room temperature below 25Β°C, away from direct sunlight
- Once reconstituted, refrigerate and use within 24 hours
- Perform patch test before full treatment to assess allergic reactions
- Avoid strenuous exercise, sun exposure, and alcohol for 24-48 hours post-treatment
Always consult with qualified medical professionals before use and ensure proper training in injection techniques.
π― Target Applications & Recommendations
| Target Application |
Symptoms/Situation |
Usage Classification |
Clinical Reason |
| Corrective Use |
Overfilling, unevenness, incorrect HA filler placement |
Filler Dissolution |
Hyaluronidase specifically breaks down hyaluronic acid bonds |
| Supportive Use |
Enhancing lipolysis procedures, reducing fibrous cellulite |
Fat-Dissolving Synergy |
Facilitates dispersion and efficacy of fat-dissolving agents |
| Emergency Use |
Vascular occlusion from filler injection |
Immediate Intervention |
Rapid dissolution to restore vascular flow |
Which Application is Right for You?
Based on your specific clinical needs and treatment goals, LIPORASE inj offers versatile solutions for both corrective and enhancement procedures. Choose the appropriate protocol focusing on your main concerns such as filler correction, body contouring enhancement, or emergency intervention.
πΉ Comprehensive Product Details
Professional Filler Dissolution ProtocolFor correcting unsatisfactory HA filler results: Reconstitute 1 vial with 3cc saline to create a solution capable of dissolving approximately 3cc of HA filler. Effects begin almost immediately with complete dissolution within 24-48 hours.Lipolysis Enhancement ProtocolFor improving fat-dissolving treatments: Mix 1 vial with 5cc saline and combine with fat-dissolving cocktail to enhance spread and efficacy throughout target adipose tissue, resulting in improved treatment outcomes.Emergency Intervention ProtocolFor vascular occlusion cases: Immediate injection around affected area using standard dissolution protocol to rapidly break down filler material and restore proper blood circulation.Treatment Depth GuidelinesInjection depth should target the superficial dermal or subcutaneous layer depending on the original filler placement or treatment objective. Precise technique ensures optimal results and patient safety.
π¦ Storage & Handling Requirements
π‘οΈ
Storage Temperature
Below 25Β°C
Room Temp
Hermetic container, away from direct sunlight
β±οΈ
Reconstituted Shelf Life
24
Hours
Refrigerated after reconstitution
π
Original Package
Stable
Long-term
Lyophilized powder form
π§ͺ
Patch Test
Required
Pre-treatment
Allergy assessment recommended
π¨βοΈ Professional Guidelines
Pre-Treatment Assessment
Comprehensive evaluation of treatment area, patient medical history, and previous filler applications. Document filler type, volume, and injection sites for optimal treatment planning.
- Verify type and volume of existing HA fillers
- Assess patient's allergy history and previous reactions
- Evaluate treatment area for signs of infection or inflammation
- Plan injection strategy based on filler depth and distribution
Treatment Execution
Professional injection techniques ensuring patient safety and optimal therapeutic outcomes. Proper sterile technique and precise dosing are essential for successful results.
- Use sterile injection technique with appropriate needle gauge
- Monitor patient response during and immediately after injection
- Document treatment parameters and patient response
- Provide clear post-treatment care instructions
Post-Treatment Monitoring
Systematic follow-up to ensure treatment effectiveness and patient satisfaction. Assessment of results and planning for additional treatments if necessary.
- Evaluate treatment response at 24-48 hour follow-up
- Document photographic evidence of treatment outcomes
- Assess need for additional treatment sessions
- Monitor for any adverse reactions or complications
β
Quality Assurance & Manufacturing
π
Manufacturer
Daehan New Pharm
Certified
π¬
Testing Standard
European Pharmacopoeia
EP Grade
β
Purity Level
Pharmaceutical
Grade
π
Product Status
Genuine
Authentic
π Technical Summary
1,500 IU Hyaluronidase Per Vial
Complete Package Contents10 vials of lyophilized Hyaluronidase powder (1,500 IU each), sterile packaging, and comprehensive professional usage guidelines for optimal treatment outcomes.Reconstitution RequirementsSterile saline solution required for reconstitution. Volume depends on intended use: 3cc for filler dissolution, 5cc for lipolysis enhancement protocols.Professional ConsultationProfessional medical consultation and proper injection training are essential for safe and effective use. Not suitable for home use or non-professional application.Compatibility InformationCompatible with most fat-dissolving solutions and can be combined with lidocaine to minimize injection discomfort. Do not use near recent botulinum toxin injection sites.
Keywords: Hyaluronidase, Dermal Filler Dissolver, Filler Correction, HA Filler Reversal, Fat-Dissolving Synergy, Cellulite Reduction, Vascular Occlusion, Corrective Enzyme, Lipolysis Enhancer, Daehan New Pharm, Genuine, Professional Use, Emergency Intervention, Aesthetic Medicine